Genesco GCO Gain (Loss) on Sale of Assets and Asset Impairment Charges
Gain (Loss) on Sale of Assets and Asset Impairment Charges at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Genesco in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges.
The official record: Genesco’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Genesco's gain (loss) on sale of assets and asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Genesco's gain (loss) on sale of assets and asset impairment charges?
- Genesco (GCO) reported gain (loss) on sale of assets and asset impairment charges of $10.11M in Q1 2026.
- How has Genesco's gain (loss) on sale of assets and asset impairment charges changed year-over-year?
- Genesco's gain (loss) on sale of assets and asset impairment charges increased by 3573.2% year-over-year, from -$291K to $10.11M.
- What is the long-term trend for Genesco's gain (loss) on sale of assets and asset impairment charges?
- Over 4 years (2022 to 2026), Genesco's gain (loss) on sale of assets and asset impairment charges has grown at a 0.0% compound annual growth rate (CAGR), from $8.06M to -$8.07M.
- What does gain (loss) on sale of assets and asset impairment charges mean?
- This metric captures the net financial impact of disposing of long-term assets and recognizing non-cash charges related to the reduction in value of assets. It reflects management's ability to optimize the asset base and provides insight into potential operational restructuring or asset underperformance. Investors monitor this to distinguish between recurring operational performance and one-time events that impact the bottom line.